> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Safety Labeling Change Posted for Ocrevus
- URL: https://www.fdaweb.com/safety-labeling-change-posted-for-ocrevus/
- Published: 2020-11-12T12:00:00.000Z
- Updated: 2026-09-14T16:36:16.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5148074

FDA has posted an 11/6 safety labeling change for Genentech’s multiple sclerosis drug Ocrevus (ocrelizumab). The [change](https://www.accessdata.fda.gov/scripts/cder/safetylabelingchanges/index.cfm?DrugNameID=1356&event=searchdetail.page&utm%5Fmedium=email&utm%5Fsource=govdelivery) affects the label’s Warnings and Precautions, Adverse Reactions, Use in Specific Populations, and Patient Counseling/Patient Information/Medication Guide sections.